The average monthly premium for Medicare Part D prescription drug coverage will increase slightly over the previous two years, the Centers for Medicare & Medicaid Services said last week.
FDA approves only 17 new drugs last year
By
Haymarket Media
Jan 05, 2007
The Food and Drug Administration last year approved only 17 new prescription drugs, the lowest number of new drug approvals in a decade, according to a new study.
Another double-digit rise in healthcare costs forecast
By
Haymarket Media
Nov 03, 2004
Employers will see their medical plan costs rise an average of 13.5%, according to a new analysis by Aon Corp.
CMS to recover $4 billion in overpayments for Part D drugs
By
Haymarket Media
Oct 15, 2007
The Centers for Medicare & Medicaid Services said that because actual drug costs were lower than expected, Part D drug plan sponsors will need to return $4 billion to the agency.
Discovery could speed sepsis treatment
By
Kimberly Marselas
Dec 01, 2014
Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by a discovery at the University of British Columbia.
British health official: Cure for dementia could come by 2020
By
Ashley Carman
Jul 11, 2013
Advances in genetics and pharmaceuticals could lead to a cure for dementia by 2020, according to United Kingdom Secretary of Health Jeremy Hunt.
Pharma company expands in Tennessee
May 03, 2017
Aphena Pharma Solutions announced it has expanded its solid-dose packaging operations in Cookeville, TN. The expansion doubled the size of the facility, increasing manufacturing and warehouse space, and...
Meditation reduces loneliness, inflammation in elderly adults, study finds
By
McKnight's Staff
Aug 15, 2012
A meditation technique reduces loneliness and chronic inflammation disorders in seniors, new research shows.
Researchers: Alzheimer’s might start in the liver
Mar 07, 2011
The brain “plaques” commonly associated with Alzheimer’s disease might actually originate in the liver, according to a startling new discovery by scientists at Scripps Research Institute.
Mayo Clinic receives patent for GeneSight
May 22, 2013
The Mayo Clinic has received a patent for a new medication selection procedure. GeneSight uses a test to prioritize the selection of medications for patients with depression, chronic pain and other psychiatric...